Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Haga

Showing results (211-220 of 213) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 213 results.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animalsM Honda, K Matsuo, T Nakasone, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 8, 1998
[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group]Y Nomura, O Abe, K Enomoto, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996M R Price, P D Rye, E Petrakou, et al.
Pageof 22

Showing results (211-220 of 213) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 213 results.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 1995
Protective immune responses induced by secretion of a chimeric soluble protein from a recombinant Mycobacterium bovis bacillus Calmette-Guérin vector candidate vaccine for human immunodeficiency virus type 1 in small animalsM Honda, K Matsuo, T Nakasone, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 8, 1998
[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group]Y Nomura, O Abe, K Enomoto, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996M R Price, P D Rye, E Petrakou, et al.
Pageof 22